The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition
Open accessAbstract
Haploinsufficiency of the SHANK3 gene is causally linked to autism spectrum disorder (ASD), and ASD-associated genes are also enriched for chromatin remodelers. Here we found that brief treatment with romidepsin, a highly potent class I histone deacetylase (HDAC) inhibitor, alleviated social deficits in Shank3-deficient mice, which persisted for ~3 weeks. HDAC2 transcription was upregulated in these mice, and knockdown of HDAC2 in prefrontal cortex also rescued their social deficits. Nuclear localization of β-catenin, a Shank3-binding protein that regulates cell adhesion and transcription, was increased in Shank3-deficient mice, which induced HDAC2 upregulation and social deficits. At the downstream molecular level, romidepsin treatment elevated the expression and histone acetylation of Grin2a and actin-regulatory genes and restored NMDA-receptor function and actin filaments in Shank3-deficient mice. Taken together, these findings highlight an epigenetic mechanism underlying social deficits linked to Shank3 deficiency, which may suggest potential therapeutic strategies for ASD patients bearing SHANK3 mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The nucleocytoplasmic shuttle protein involved in both cell adhesion and transcriptional regulation, β-catenin, is found to link the loss of Shank3 in the synapse to the upregulation of HDAC2 and EHMT1/2 transcription in the nucleus 145,146 (Fig. 3).”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [145]
In the citing paper
“In PFC of Shank3-deficient mice, the loss of histone acetylation and upregulation of HDAC2 have been identified 145.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [145]
In the citing paper
“Systemic administration of the class I HDAC inhibitor romidepsin or MS-275 leads to the robust and persistent alleviation of social deficits, as well as the restoration of actin regulators and NMDAR function in PFC 144,145.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [145]
In the citing paper
“A recent series of studies have shown that targeting epigenetic enzymes to adjust gene expression and ameliorate synaptic defects in PFC is a potential strategy to normalize behavioral phenotypes associated with autism 144–147.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [145]
In the citing paper
“consistent with the significant involvement of NMDARs in ASD [101–103].”
From 16p11.2 Copy Number Variations and Neurodevelopmental Disorders (2020) · cites this paper as [102]
In the citing paper
“This study suggests NMDAR hypofunction in PFC as a core mechanism in 16p11.2 deletion-linked phenotypes, consistent with the significant involvement of NMDARs in ASD [101–103].”
From 16p11.2 Copy Number Variations and Neurodevelopmental Disorders (2020) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Cutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Meeting of minds: the medial frontal cortex and social cognition
Amodio, D. M., & Frith, C. D. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1884 · Cited by 3,782
Synaptic, transcriptional and chromatin genes disrupted in autism
Study, T. D., De Rubeis, S., Autism, H. M. C. F., UK10K Consortium, The Autism Sequencing Consortium, He, X., Goldberg, A. P., Poultney, C. S., Samocha, K., Ercument Cicek, A., et al. (2014) · Nature · doi:10.1038/nature13772 · Cited by 2,746
HDAC2 negatively regulates memory formation and synaptic plasticity
Guan, J.-S., Haggarty, S. J., Giacometti, E., Dannenberg, J.-H., Joseph, N., Gao, J., Nieland, T. J. F., Zhou, Y., Wang, X., Mazitschek, R., et al. (2009) · Nature · doi:10.1038/nature07925 · Cited by 1,644
Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602
The many faces and functions of β‐catenin
Valenta, T., Hausmann, G., & Basler, K. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.150 · Cited by 1,598
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., Lascola, C. D., Fu, Z., & Feng, G. (2011) · Nature · doi:10.1038/nature09965 · Cited by 1,570
Cited by
Sorted by citations
Items 101–200 of 245
Hassib, L., Kanashiro, A., Pedrazzi, J. F. C., Vercesi, B. F., Higa, S., Arruda, Í., Soares, Y., de Souza, A. P., Barichello, T., Guimarães, F. S., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111385 · Cited by 19
SHANK family on stem cell fate and development
Liu, X., Yuan, M., Lau, B. W.-M., & Li, Y. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05325-3 · Cited by 21
Murari, K., Abushaibah, A., Rho, J. M., Turner, R. W., & Cheng, N. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2023.104565 · Cited by 20
Targeting epigenetic enzymes for autism treatment
Yan, Z. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.06.009 · Cited by 18
Self-citationTargeting Shank3 deficiency and paresthesia in autism spectrum disorder: A brief review
Huang, M., Qi, Q., & Xu, T. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1128974 · Cited by 21
Wan, L., Liu, D., Xiao, W., Zhang, B., Yan, X., Luo, Z., & Xiao, B. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01054-x · Cited by 20
Lin, R., Learman, L. N., Bangash, M. A., Melnikova, T., Leyder, E. C., Reddy, S. C., Naidoo, N. N., Park, J. M., Savonenko, A. V., & Worley, P. F. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110014 · Cited by 18
Lin, C.-W., Septyaningtrias, D. E., Chao, H., Konda, M., Atarashi, K., Takeshita, K., Tamada, K., Nomura, J., Sasagawa, Y., Tanaka, K. Y., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01566-y · Cited by 17
Yue, S., Wang, Y., & Wang, Z. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109204 · Cited by 19
Self-citationRein, B. A., Yan, Z., & Wang, Z. (2019) · Genes Brain & Behavior · doi:10.1111/gbb.12610 · Cited by 19
Self-citationZhu, F., Shi, Q. W., Jiang, Y., Zhang, Y., & Zhao, H. (2024) · Molecular Autism · doi:10.1186/s13229-024-00587-4 · Cited by 17
Best, A. J., Braunschweig, U., Wu, M., Farhangmehr, S., Pasculescu, A., Lim, J. J., Comsa, L. C., Jen, M., Wang, J., Datti, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50399-6 · Cited by 15
Kim, Y.-E., Kim, M., Kim, S., Lee, R. H., Ujihara, Y., Marquez-Wilkins, E. M., Jiang, Y., Yang, E., Kim, H., Lee, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56720-1 · Cited by 16
Ryu, Y., Park, H., Go, J., Choi, D., Choi, Y., Rhee, M., Lee, C., & Kim, K. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05812-z · Cited by 16
Lu, R., Cui, S., Wang, X., Chen, L., Liu, F., Gao, J. Y., & Wang, W. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.07.024 · Cited by 17
Jin, C., Kang, H. R., Kang, H., Zhang, Y., Lee, Y., Kim, Y., & Han, K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00228 · Cited by 18
Current trends of high-risk gene Cul3 in neurodevelopmental disorders
Lin, P., Yang, J., Wu, S., Ye, T., Zhuang, W., Wang, W., & Tan, T. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1215110 · Cited by 14
Jin, C., Kang, H., Yoo, T., Ryu, J. R., Yoo, Y.-E., Ma, R., Zhang, Y., Kang, H. R., Kim, Y., Seong, H., et al. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.614435 · Cited by 14
Rapanelli, M., Wang, W., Hurley, E. L., Feltri, M. L., Pittenger, C., Frick, L. R., & Yan, Z. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02306-8 · Cited by 16
Self-citationWang, W., Tan, T., Cao, Q., Zhang, F., Rein, B. A., Duan, W., & Yan, Z. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac048 · Cited by 16
Self-citationWang, J., Xu, C., Liu, C., Zhou, Q., Chao, G., & Jin, Y. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110314 · Cited by 13
Chu, M.-C., Wu, H.-F., Lee, C. J., Chung, Y.-J., Chi, H., Chen, P. S., & Lin, H. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00835-w · Cited by 14
Exploratory analysis of L1 retrotransposons expression in autism
Spirito, G., Filosi, M., Domenici, E., Mangoni, D., Gustincich, S., & Sanges, R. (2023) · Molecular Autism · doi:10.1186/s13229-023-00554-5 · Cited by 15
Identification of a molecular network regulated by multiple ASD high risk genes
Wan, L., Yang, G., & Yan, Z. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae058 · Cited by 13
Self-citationEarly Chronic Memantine Treatment-Induced Transcriptomic Changes in Wild-Type and Shank2-Mutant Mice
Yoo, Y.-E., Lee, S., Kim, W., Kim, H., Chung, C., Ha, S., Park, J., Chung, Y., Kang, H., & Kim, E. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.712576 · Cited by 12
Chen, X. '., Chen, T., Dong, C., Chen, H., Dong, X., Yang, L., Hu, L., Wang, H., Wu, B., Yao, Y., et al. (2022) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2022.02.011 · Cited by 14
Lee, Y., Kang, H., Jin, C., Zhang, Y., Kim, Y., & Han, K. (2019) · Animal Cells and Systems · doi:10.1080/19768354.2019.1595142 · Cited by 13
Mishra, A., Prabha, P. K., Singla, R., Kaur, G., Sharma, A. R., Joshi, R., Suroy, B., & Medhi, B. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00060 · Cited by 14
Megagiannis, P., Suresh, R., Rouleau, G. A., & Zhou, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114562 · Cited by 12
Drug Repurposing Patent Applications March–June 2022
Mucke, H. A. (2022) · Assay and Drug Development Technologies · doi:10.1089/adt.2022.065 · Cited by 11
Unravelling the role of SHANK3 mutations in targeted therapies for autism spectrum disorders
Li, X. (2024) · Discover Psychology · doi:10.1007/s44202-024-00223-5 · Cited by 14
Promising therapeutic aspects in human genetic imprinting disorders
Chao, Y., Qin, Y., Zou, X., Wang, X., Hu, C., Xia, F., & Zou, C. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01369-6 · Cited by 14
Ni, P., Zhou, C., Liang, S., Jiang, Y., Liu, D., Shao, Z., Noh, H., Zhao, L., Yang, T., Zhang, C., et al. (2023) · Advanced Science · doi:10.1002/advs.202300455 · Cited by 10
Self-citationMaussion, G., Rocha, C., Bernard, G., Beitel, L. K., & Durcan, T. M. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00225 · Cited by 11
Epigenetics and Pharmacoepigenetics of Neurodevelopmental and Neuropsychiatric Disorders
Cacabelos, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00022-x · Cited by 11
Carballo, L. G. H., Li, P., Senek, R., & Yan, Z. (2024) · The Journal of Physiology · doi:10.1113/jp285875 · Cited by 11
Self-citationAomine, Y., Shimo, Y., Sakurai, K., Abe, M., Macpherson, T., Ozawa, T., & Hikida, T. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16227 · Cited by 9
PTN activity in quiescent neural stem cells mediates Shank3 overexpression-induced manic behavior
Kim, H., Cho, B., Kim, H. K., Kang, S., An, S., Kwon, D., Kim, H. Y., & Kim, J. (2025) · Nature Communications · doi:10.1038/s41467-025-57699-5 · Cited by 11
Inhibition of histone deacetylase 5 ameliorates abnormalities in 16p11.2 duplication mouse model
Rein, B. A., Conrow‐Graham, M., Frazier, A., Cao, Q., & Yan, Z. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108893 · Cited by 11
Self-citationBludau, A., Paul, A., Neumann, I. D., & Menon, R. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02310-y · Cited by 10
Wei, J., Dai, S., Yan, Y., Li, S., Yang, P., Zhu, R., Huang, T., Li, X., Duan, Y., Wang, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39411-7 · Cited by 10
Self-citationSuda, K., Muraoka, Y., Ortega-Yáñez, A., Yoshida, H., Kizu, F., Hochin, T., Kimurâ, H., & Yamaguchi, M. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111673 · Cited by 10
Immune Modulatory Treatments for Autism Spectrum Disorder
Thom, R. P., & McDougle, C. J. (2020) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2020.100836 · Cited by 9
Dongdong, Z., Huo, Y., Zheng, N., Zhu, X., Yang, D., Zhou, Y., Wang, S., Jiang, Y., Wu, Y., & Zhang, Y. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003047 · Cited by 10
Synaptic Deficits in Adnp‐ Mutant Mice Are Ameliorated by Histone Demethylase LSD1 Inhibition
Lin, C., Ren, Y., Tam, K. W., Conrow‐Graham, M., & Yan, Z. (2025) · Autism Research · doi:10.1002/aur.70069 · Cited by 8
Self-citationAdvancing precision diagnosis in autism: Insights from large-scale genomic studies
Kim, S.-W., & An, J. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100248 · Cited by 10
Lee, S., Kang, H., Jung, H., Kim, E., & Lee, E. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.683196 · Cited by 9
Severino, L., Kim, J., Nam, M., & McHugh, T. J. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105559 · Cited by 9
Lu, X., Ni, P., Suárez-Meade, P., Ma, Y., Forrest, E., Wang, G., Wang, Y., Quiñones‐Hinojosa, A., Gerstein, M., & Jiang, Y.-H. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114376 · Cited by 10
Alhazmi, S., Alzahrani, M., Farsi, R. M., Alharbi, M. G., Algothmi, K. M., Alburae, N. A., Ganash, M., Azhari, S. A., Basingab, F. S., Almuhammadi, A., et al. (2022) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s366826 · Cited by 8
Purushotham, S. S., Reddy, N. M. N., D’Souza, M. N., Choudhury, N. R., Ganguly, A., Gopalakrishna, N., Muddashetty, R. S., & Clement, J. P. (2022) · Experimental Brain Research · doi:10.1007/s00221-022-06448-x · Cited by 8
Wang, Y., Liu, J., Yue, S., Chen, L., Singh, A. K., Yu, T., Calipari, E. S., & Wang, Z.-J. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02102-6 · Cited by 7
Self-citationCancer drug repurposing in autism spectrum disorder
Pedini, G., Chen, C., Achsel, T., & Bagni, C. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.09.008 · Cited by 7
Inhibition of GSK3α,β rescues cognitive phenotypes in a preclinical mouse model of CTNNB1 syndrome
Alexander, J., Vazquez-Ramirez, L., Lin, C., Antonoudiou, P., Maguire, J. L., Wagner, F. F., & Jacob, M. H. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00110-5 · Cited by 9
Mitra, I., Huang, B., Mousavi, N., Ma, N., Lamkin, M., Yanicky, R., Shleizer-Burko, S., Lohmueller, K. E., & Gymrek, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.04.974170 · Cited by 7
Evaluation of circulating miRNAs and mRNAs expression patterns in autism spectrum disorder
Abdelrahman, A. H., Eid, O. M., Ibrahim, M. H., El-Fattah, S. N. A., Eid, M. M., & Meguid, N. A. (2021) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-021-00202-8 · Cited by 7
López-Rodríguez, A. B., Murray, C., Kealy, J., Towns, C., Nazmi, A., Arnold, L., Doran, M. M., Lowry, J., & Cunningham, C. M. (2023) · Molecular Autism · doi:10.1186/s13229-023-00569-y · Cited by 7
Wang, T., Zhang, S., Luo, M., Lu, M., Wei, L., Zhou, X., Wang, H., & Xu, D. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115797 · Cited by 8
Cheng, K., Larabee, S. M., Tolaymat, M., Hanscom, M., Shang, A. C., Schledwitz, A., Hu, S., Drachenberg, C. B., Zhan, M., Chahdi, A., et al. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00415.2020 · Cited by 6
Sontheimer, H. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821228-8.00014-7 · Cited by 5
Targeting the Zinc-Dependent Histone Deacetylases (HDACs) for Drug Discovery
Ganesan, A. (2019) · Topics in medicinal chemistry · doi:10.1007/7355_2019_68 · Cited by 6
Wu, Q., Zhou, D., Wu, R., Shi, R., Shen, X., Jin, N., Gu, J., Gu, J.-H., Liu, F., & Chu, D. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.11.008 · Cited by 5
Diaz, L., Kong, A. X., Zhang, P., Chi, J., Pham, K. T., Johnson, M., Eno, A. F., Douglas, I., Mao, Y., MacDonald, J. W., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.19.683261 · Cited by 5
Hamada, N., Nishijo, T., Iwamoto, I., Shifman, S., & Nagata, K. (2024) · Cells · doi:10.3390/cells13060540 · Cited by 4
Uehara, J. M., Acosta, M. G., Bello, E. P., & Belforte, J. E. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02051-0 · Cited by 4
Borbélyová, V., Szabó, J., Sušienková, P., Potvin, J., Belvončíková, P., Groß, T., Jančovičová, A., Bačová, Z., Rašková, B., Szadvári, I., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26135927 · Cited by 5
HISTORY, EPIDEMIOLOGY, AND PUTATIVE MOLECULAR BASIS OF AUTISM SPECTRUM DISORDER
Alharbi, M. G. (2023) · Applied Ecology and Environmental Research · doi:10.15666/aeer/2101_805821 · Cited by 4
Kim, Y., Kim, K., Lee, Y., Min, H., Ko, Y., Lee, B., Hur, K., Kim, S., Lee, S., & Jang, C. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16427 · Cited by 4
Wang, W., Ma, J., Sun, X., Ba, W., Meng, X., Zhu, Y., Leng, L., & Li, C. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.131 · Cited by 4
An overview of oxytocin integrative mechanisms in autism spectrum disorder
Lal, N., Song, B., Zhang, C., Al-Shehari, W. A., Jabeen, S., Ahmed, N., Edrees, W. H., Gupta, R., Soomro, S., Cui, F., et al. (2025) · Discover Mental Health · doi:10.1007/s44192-025-00331-1 · Cited by 3
Adeniyi, I. A., & Sa, O. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02475-3 · Cited by 4
Ojha, S. K., Kartawy, M., Hamoudi, W., Tripathi, M. K., Aran, A. A., & Amal, H. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03514-6 · Cited by 4
Expression of SH3 and Multiple Ankyrin Repeat Domains Protein 3 in Mouse Retina
Xu, Y., Wang, Y., Tong, G., Li, L., Cheng, J., Zhang, L., Xu, Q., Wang, L., & Zhang, P. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.795668 · Cited by 3
Ma, K., Zhang, D., McDaniel, K., Webb, M., Newton, S. S., Lee, F. S., & Qin, L. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1496930 · Cited by 3
Self-citationYang, S.-S., He, Q., Gu, X., Liu, S., Ke, W., Chen, L., Li, B., Shu, Y., & Gao, W. (2025) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2025.100486 · Cited by 3
Arta, R. K., Watanabe, Y., Egawa, J., Lemmon, V., & Someya, T. (2025) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13847 · Cited by 4
Autism-modifying therapy based on the promotion of a brain enzyme: An introductory case-report
Béroule, D., LIMSI-CNRS, R. J. V. N., & CRIIGEN, 4. R. M. (2019) · AIMS molecular science · doi:10.3934/molsci.2019.3.52 · Cited by 3
Tu, G., Guo, Y., Xiao, R., Tang, L., Hu, M., & Liao, B. (2023) · Neurorehabilitation and neural repair · doi:10.1177/15459683231152814 · Cited by 4
Paving the way toward treatment solutions for CTNNB1 syndrome: a patient organization perspective
Miroševič, Š., Khandelwal, S., Amerson, E., Parks, E., Parks, M., Cochran, L., Hernández, A. G., Ferraro, M., Lisowski, L., Perez-Iturralde, A., et al. (2025) · Therapeutic Advances in Rare Disease · doi:10.1177/26330040251318355 · Cited by 3
Amar, M., Pramod, A. B., Yu, N., Herrera, V. M., Qiu, L. R., Losada, P. M., Zhang, P., Trujillo, C. A., Ellegood, J., Urresti, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.07.939256 · Cited by 3
Male sex hormones increase excitatory neuron production in developing human neocortexPreprint
Kelava, I., Chiaradia, I., Pellegrini, L., Kalinka, A. T., & Lancaster, M. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.24.353359 · Cited by 3
Pérez‐Sisqués, L., Bhatt, S., Caruso, A., Ahmed, M. U., Gileadi, T. E., Spring, S., Hendy, E., Taylor‐Papadimitriou, J., Cash, D., Clifton, N. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.28.596232 · Cited by 3
Lasting effect of psilocybin on sociability can be blocked by DNA methyltransferase inhibitionPreprint
Song, C., Chang, T., Buchborn, T., & Knöpfel, T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.10.642385 · Cited by 4
Ma, K., McDaniel, K., Zhang, D., Webb, M., & Qin, L. (2024) · Genes · doi:10.3390/genes15121619 · Cited by 2
Self-citationEpigenetic Mechanisms of Autism Spectrum Disorders
Yan, Z. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_103 · Cited by 2
Self-citationFerhat, A.-T. L. S., Verpy, E., Biton, A., Forget, B., de Chaumont, F., Mueller, F., Anne-Marie, L. S., Coqueran, S., Schmitt, J., Rochefort, C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.19.476922 · Cited by 2
Huang, W.-C., Mandell, K. A. P., Aryal, S., Song, B. J., Valle-Tojeiro, A., Goble, N., Geng, C., Asan, A. S., Liu, X., Dennis, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.18.638656 · Cited by 2
Genetic etiology and neurobiological mechanisms of autism spectrum disorders
ZHANG, J., XiangBin, J. I. A., Xia, K., Guo, H., & Li, J. (2024) · Scientia Sinica Vitae · doi:10.1360/ssv-2024-0105 · Cited by 1
The Use of Nutraceutical and Pharmacological Strategies in Murine Models of Autism Spectrum Disorder
Bonetti, M., Borsani, E., & Bonomini, F. (2024) · Cells · doi:10.3390/cells13242036 · Cited by 1
Lainšček, D., Forstnerič, V., & Miroševič, Š. (2025) · Mammalian Genome · doi:10.1007/s00335-025-10105-3 · Cited by 1
Emerging Epigenetic Therapeutics and Diagnostics for Autism Spectrum Disorder
Kao, C., Lim, K. K., & Chen, E. S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070491 · Cited by 1
Gao, J., Wu, S., Yang, J., Ye, T., Yang, J., Shen, W., Chen, X., Huang, L., Pang, R., Lin, P., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03505-1 · Cited by 3
Derepression of transposable elements in the mouse prefrontal cortex disrupts social behavior
Kim, R. K., Smith, C. A., Truby, N. L., Strandberg, S. R., Bell, J. L., Carwile, N., Silva, G. M., Neve, R. L., Aung, T., Cui, X., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2510663122 · Cited by 1
Epigenetic treatment of synaptic and behavioral deficits in Dyrk1a-mutant mice
Lin, C.-H., Yu, M., Patel, P. J., Li, P., & Yan, Z. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02353-x · Cited by 1
Self-citationSarwar, T., Alharbi, H. O. A., Alhumaydhi, F. A., Khan, R. M., & Rahmani, A. H. (2026) · Open Life Sciences · doi:10.1515/biol-2025-1272 · Cited by 1
Pérez‐Sisqués, L., Bhatt, S. R., Caruso, A., Robb, J. L., Donovan, A. P. A., Bamford, R. A., Torres-Cano, A., Spring, S., Hendy, E., Gileadi, T. E., et al. (2026) · Science Advances · doi:10.1126/sciadv.adq6577 · Cited by 1
Li, P., Men, S., Patel, P. J., Saleem, K., Zhong, P., Tam, K. W., Feng, J., & Yan, Z. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03848-1 · Cited by 1
Self-citationHistone deacetylase 4 inhibition ameliorates the social deficits induced by Ephrin-B2 mutation
Ju, P., Chen, J., Ma, L., Cheng, Y., Liu, J., Sun, Y., Zhu, C., Shen, Z., wang, W., Peng, Y., et al. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110622 · Cited by 1
Rodent Models for ASD Biomarker Development
Lee, H. H. C., & Şahin, M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69491-2_8 · Cited by 2
Nevado, J. B., Ciceri, F., Fenellós, C. B., Tenorio, J. A., Maes, T., Xaus, J., Buesa, C., & Lapunzina, P. D. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1511962 · Cited by 1
Metadata
- Authors
- Qin, L., Ma, K., Wang, Z.-J., Hu, Z., Matas, E., Wei, J., & Yan, Z.
- Affiliations
- University at Buffalo, State University of New York (US)
- Corresponding author
- Yan, Zhen
- Venue
- Nature Neuroscience
- Published
- 2018-03-12
- Volume
- 21
- Issue
- 4
- Pages
- 564-575
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC5876144
- OpenAlex
- W2790053528
- Cited by
- 240
- References
- 48
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 33 · 2023: 30 · 2022: 35 · 2021: 35 · 2020: 21 · 2019: 28 · 2018: 10
- FWCI
- 14.41
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-06-05)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Nancy Lurie Marks Family Foundation
- National Institutes of Health
- National Institute of Mental Health (R41MH112237, R01MH108842)
- National Institute on Drug Abuse (R01DA037618)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- SHANK3, autism spectrum disorder, social dysfunction, HDAC2, histone deacetylase inhibition, romidepsin, β-catenin, epigenetic regulation, NMDA receptor, GRIN2A, actin cytoskeleton, prefrontal cortex, chromatin remodeling
- MeSH terms
- Animals, Autistic Disorder, Disease Models, Animal, Exploratory Behavior, Gene Expression Regulation, Grooming, Histone Deacetylases, Locomotion, Male, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Nerve Tissue Proteins, Psychomotor Performance, Social Behavior Disorders, Prefrontal Cortex, Depsipeptides, Mice, Synaptic Potentials, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review